Palvella Therapeutics (PVLA) Exchange Rate Effect (2014 - 2026)
Palvella Therapeutics (PVLA) reported Exchange Rate Effect of -$15000.0 for Q1 2026, down 150.0% year-over-year from $30000.0 in Q1 2025, and up 97.54% on a QoQ basis from -$610000.0 in Q4 2025.
Palvella Therapeutics (PVLA) has 13 years of Exchange Rate Effect data on file, last reported at -$15000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 150.0% year-over-year to -$15000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37000.0 (up 1333.33% YoY) and the FY2025 annual result came in at $46000.0, up 1433.33% from the prior year.
- Exchange Rate Effect improved to -$15000.0 in Q1 2026 per PVLA's latest filing, from -$610000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.9 million in Q4 2022 and bottomed at -$3.3 million in Q2 2022.
- The 5-year median for Exchange Rate Effect is -$45000.0 (2023), against an average of -$367214.3.
- The widest annual swing landed in 2022, when Exchange Rate Effect jumped 315.39%; it then sank 20433.33% in 2025.
- Tracing PVLA's Exchange Rate Effect over 5 years: stood at $1.9 million in 2022, then sank by 103.86% to -$75000.0 in 2023, then soared by 104.0% to $3000.0 in 2024, then slumped by 20433.33% to -$610000.0 in 2025, then soared by 97.54% to -$15000.0 in 2026.
- Per Business Quant, the three latest PVLA Exchange Rate Effect figures stand at -$15000.0 (Q1 2026), -$610000.0 (Q4 2025), and $770000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | -15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,000.00 |
| Mar 31, 2026 | -15,000.00 |
| Dec 31, 2025 | -610,000.00 |
| Dec 31, 2025 | -610,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2023 | -75,000.00 |
| Dec 31, 2023 | -75,000.00 |
| Sep 30, 2023 | -337,000.00 |
| Sep 30, 2023 | -337,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 1.95 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | -2.81 Mn |
| Sep 30, 2022 | -2.81 Mn |
| Jun 30, 2022 | -3.32 Mn |
| Jun 30, 2022 | -3.32 Mn |
| Mar 31, 2022 | -994,000.00 |
| Mar 31, 2022 | -994,000.00 |
| Dec 31, 2021 | -903,000.00 |
| Dec 31, 2021 | -903,000.00 |
| Sep 30, 2021 | -1.13 Mn |
| Sep 30, 2021 | -1.13 Mn |
| Jun 30, 2021 | -32,000.00 |
| Jun 30, 2021 | -32,000.00 |
| Mar 31, 2021 | -1.13 Mn |
| Mar 31, 2021 | -1.13 Mn |
| Dec 31, 2020 | 2.04 Mn |
| Dec 31, 2020 | 2.04 Mn |
| Sep 30, 2020 | 2.18 Mn |
| Sep 30, 2020 | 2.18 Mn |
| Jun 30, 2020 | 637,000.00 |
| Jun 30, 2020 | 637,000.00 |
| Mar 31, 2020 | -112,000.00 |
| Mar 31, 2020 | -112,000.00 |
| Dec 31, 2019 | 382,000.00 |
| Dec 31, 2019 | 382,000.00 |
| Sep 30, 2019 | -525,000.00 |
| Sep 30, 2019 | -525,000.00 |
| Jun 30, 2019 | 348,000.00 |
| Jun 30, 2019 | 348,000.00 |
| Mar 31, 2019 | -2.35 Mn |
| Mar 31, 2019 | -2.35 Mn |
| Dec 31, 2018 | -347,000.00 |
| Dec 31, 2018 | -347,000.00 |
| Sep 30, 2018 | -409,000.00 |
| Sep 30, 2018 | -409,000.00 |
| Jun 30, 2018 | -1.26 Mn |
| Jun 30, 2018 | -1.26 Mn |
| Mar 31, 2018 | 438,000.00 |
| Mar 31, 2018 | 438,000.00 |
| Dec 31, 2017 | -3.20 Mn |
| Dec 31, 2017 | -3.20 Mn |
| Sep 30, 2017 | 2.66 Mn |
| Sep 30, 2017 | 2.66 Mn |
| Jun 30, 2017 | 801,000.00 |
| Jun 30, 2017 | 801,000.00 |
| Mar 31, 2017 | 295,000.00 |
| Mar 31, 2017 | 295,000.00 |
| Dec 31, 2016 | -236,007.00 |
| Dec 31, 2016 | -236,007.00 |
| Sep 30, 2016 | 16,408.00 |
| Sep 30, 2016 | 16,408.00 |
| Jun 30, 2016 | 71,835.00 |
| Jun 30, 2016 | 71,835.00 |
| Mar 31, 2016 | -119,236.00 |
| Mar 31, 2016 | -119,236.00 |
| Dec 31, 2015 | -72,227.00 |
| Dec 31, 2015 | -72,227.00 |
| Sep 30, 2015 | 182,345.00 |
| Sep 30, 2015 | 182,345.00 |
| Jun 30, 2015 | 20,635.00 |
| Jun 30, 2015 | 20,635.00 |
| Mar 31, 2015 | -545,633.00 |
| Mar 31, 2015 | -545,633.00 |
| Sep 30, 2014 | -128,763.00 |
| Sep 30, 2014 | -128,763.00 |
| Jun 30, 2014 | -17,033.00 |
| Jun 30, 2014 | -17,033.00 |
| Mar 31, 2014 | 742.00 |
| Mar 31, 2014 | 742.00 |